Osaic Holdings’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $149K | Sell |
14,382
-3,309
| -19% | -$34.3K | ﹤0.01% | 3845 |
|
|
2025
Q1 | $126K | Buy |
17,691
+10,697
| +153% | +$76K | ﹤0.01% | 4000 |
|
|
2024
Q4 | $81.4K | Sell |
6,994
-28,361
| -80% | -$330K | ﹤0.01% | 4330 |
|
|
2024
Q3 | $727K | Sell |
35,355
-1,774
| -5% | -$36.5K | ﹤0.01% | 2533 |
|
|
2024
Q2 | $831K | Sell |
37,129
-30
| -0.1% | -$671 | ﹤0.01% | 2339 |
|
|
2024
Q1 | $1.02M | Buy |
37,159
+1,278
| +4% | +$35.2K | ﹤0.01% | 2303 |
|
|
2023
Q4 | $1.09M | Buy |
35,881
+11,878
| +49% | +$362K | ﹤0.01% | 2431 |
|
|
2023
Q3 | $759K | Buy |
24,003
+3,978
| +20% | +$126K | ﹤0.01% | 2882 |
|
|
2023
Q2 | $818K | Sell |
20,025
-1,323
| -6% | -$54K | ﹤0.01% | 2697 |
|
|
2023
Q1 | $794K | Buy |
21,348
+1,034
| +5% | +$38.5K | ﹤0.01% | 2694 |
|
|
2022
Q4 | $709K | Buy |
20,314
+12,722
| +168% | +$444K | ﹤0.01% | 2710 |
|
|
2022
Q3 | $423K | Buy |
7,592
+15
| +0.2% | +$836 | ﹤0.01% | 3046 |
|
|
2022
Q2 | $391K | Sell |
7,577
-1,068
| -12% | -$55.1K | ﹤0.01% | 3172 |
|
|
2022
Q1 | $826K | Buy |
8,645
+88
| +1% | +$8.41K | ﹤0.01% | 2748 |
|
|
2021
Q4 | $1.01M | Buy |
8,557
+360
| +4% | +$42.6K | ﹤0.01% | 2392 |
|
|
2021
Q3 | $1.1M | Sell |
8,197
-2,389
| -23% | -$321K | ﹤0.01% | 2256 |
|
|
2021
Q2 | $1.72M | Sell |
10,586
-1,311
| -11% | -$213K | ﹤0.01% | 1852 |
|
|
2021
Q1 | $954K | Buy |
11,897
+810
| +7% | +$65K | ﹤0.01% | 2269 |
|
|
2020
Q4 | $602K | Buy |
11,087
+1,466
| +15% | +$79.6K | ﹤0.01% | 2474 |
|
|
2020
Q3 | $191K | Sell |
9,621
-291
| -3% | -$5.78K | ﹤0.01% | 3291 |
|
|
2020
Q2 | $208K | Sell |
9,912
-3,627
| -27% | -$76.1K | ﹤0.01% | 3100 |
|
|
2020
Q1 | $168K | Buy |
+13,539
| New | +$168K | ﹤0.01% | 3033 |
|